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Impact of Peer Review in the Radiation Treatment
Planning Process: Experience of a Tertiary Care
University Hospital in Pakistan
Bilal Mazhar Qureshi, MBBS1; Muhammad Atif Mansha, MBBS, MD1; Muneeb Uddin Karim, MBBS1; Asim Haﬁz, MBBS1;
Nasir Ali, MBBS1; Benazir Mirkhan, MBBS1; Fatima Shaukat, MBBS1; Maria Tariq, MBBS1; and Ahmed Nadeem Abbasi, MBBS1

abstract

PURPOSE To evaluate and report the frequency of changes in radiation therapy treatment plans after peer review
in a simulation review meeting once a week.
MATERIALS AND METHODS Between July 1 and August 31, 2016, the radiation plans of 116 patients were
discussed in departmental simulation review meetings. All plans were ﬁnalized by the primary radiation oncologist before presenting them in the meeting. A team of radiation oncologists reviewed each plan, and their
suggestions were documented as no change, major change, minor change, or missing contour. Changes were
further classiﬁed as changes in clinical target volume, treatment ﬁeld, or dose. All recommendations were
stratiﬁed on the basis of treatment intent, site, and technique. Data were analyzed by Statistical Package for the
Social Sciences and are presented descriptively.
RESULTS Out of 116 plans, 26 (22.4%) were recommended for changes. Minor changes were suggested in 15
treatment plans (12.9%) and a major change in 10 (8.6%), and only one plan was suggested for missing
contour. The frequency of change recommendations was greater in radical radiation plans than in palliative
plans (92.3% v 7.7%). The head and neck was the most common treatment site recommended for any changes
(42.3%). Most of the changes were recommended in the technique planned with three-dimensional conformal
radiation therapy (50%). Clinical target volume (73.1%) was identiﬁed as the most frequent parameter suggested for any change, followed by treatment ﬁeld (19.2%) and dose (0.08%).
CONCLUSION Peer review is an important tool that can be used to overcome deﬁciencies in radiation treatment
plans, with a goal of improved and individualized patient care. Our study reports changes in up to a quarter of
radiotherapy plans.
J Global Oncol. © 2019 by American Society of Clinical Oncology
Licensed under the Creative Commons Attribution 4.0 License
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Ensuring a high level of clinical quality in the practice
of radiation oncology has become increasingly important. The advancing knowledge about diseases and
the increasing complexity of radiation planning and
delivery methods can make radiation therapy vulnerable to errors.1 A considerable variation in target volume delineation among radiation oncologists may
occur, which can inﬂuence local tumor control and
can result in undesirable complications in patients.2
These differences exist despite adherence to wellestablished organ dose criteria and uniform contouring guidelines.3 Therefore, a process is required to
prevent inadequacies in contouring and radiation
treatment planning.
Quality assurance (QA) is a systematic way of determining inadequacies in any process by meeting
a required set of speciﬁcations or expectations. A QA

program provides a uniﬁed set of quality indicators that
focus on machines, personnel, and patients to ensure
safe and effective use of radiation therapy.4 Peer review is an important measure for QA in radiation
oncology.5 It has been deﬁned as “the evaluation of
creative work or performance by other people in the
same ﬁeld to enhance the quality of work or the
performance of colleagues.”6 A meta-analysis has
shown that an audit and feedback can be effective in
improving professional practice.7 However, there is
a dearth of quality data in this regard in the ﬁeld of
radiation oncology, and guidelines regarding peer
review with speciﬁc recommendations are few.8
Recognizing the need for peer review in the radiation
therapy treatment planning process, a simulation review meeting (SRM) was held once a week in the
radiation oncology department starting from 2006 to
December 2016. All patients for whom radiation
therapy was being planned were discussed routinely in
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the SRM after undergoing the initial planning processes of
contouring and ﬁeld arrangements. The SRM included
a review of the planned treatment by all the radiation oncologists, and changes were recommended and made as
a result of peer review, with consensus. The objective of this
study was to evaluate whether peer review in weekly SRMs
inﬂuences the radiation therapy treatment planning
process.
MATERIALS AND METHODS
This study was conducted from July 1 to August 31, 2016,
after approval by the institutional ethical review committee.
Patients who were booked for external beam radiation
therapy and underwent simulation were discussed routinely in the weekly SRM of the radiation oncology section of
Aga Khan University (AKU) Hospital. All patients, regardless of intent of treatment or technique of delivering radiotherapy, were included in the study. Before discussion
in the SRM, the contouring of target volume was completed
and approved by the primary consultant radiation oncologist. Each plan was reviewed by at least two or three
radiation oncologists. All modiﬁcations were categorized as
no change, minor change, major change, or missing
contour (Table 1). Each change was further classiﬁed as
change in clinical target volume (CTV), treatment ﬁeld, or
dose. Modiﬁcation frequency was analyzed chronologically
and by treatment intent, tumor site, and treatment technique. Intent of treatment was recorded as either curative or
palliative. Tumor sites included the brain, head and neck,
thorax, abdomen, pelvis, extremity, and others. Treatment
techniques were two dimensional, three-dimensional
conformal radiation therapy (3D-CRT), and intensity
modulated radiation therapy (IMRT). Data were analyzed
by Statistical Package for the Social Sciences version 23
(SPSS, Chicago, IL) and are presented descriptively.
RESULTS
The study was conducted for a period of 2 months, during
which the radiation treatment plans of 116 patients with
cancer were reviewed in the weekly SRM. A median of three
consultant radiation oncologists attended the SRM, with
a range of two to four, together with radiation oncology
residents and medical physicists.
Out of 116 patients, 96 (82.8%) were planned to be treated
with curative intent, and 20 (17.2%) were planned to be
treated with palliative intent. Head and neck (n = 47
[40.5%]) was the most common reviewed site, followed by
the thorax (n = 30 [25.9%]) and pelvis (n = 17 [14.7%]).
The most frequent technique used in treatment planning
was 3D-CRT, which was used in 71 cases (61.2%), followed by IMRT (n = 30 [25.9%]). A total of 26 changes
(22.6%) were recommended in radiation treatment plans.
Minor changes were recommended in 15 reviewed cases
(12.9%), whereas a major change was recommended in 10
cases (8.6%; Table 2). Most changes were suggested in
CTV (n = 19 [73.1%]), with the least changes suggested in

the prescribed dose (n = 2 [0.08%]). Additional classiﬁcation of changes with respect to CTV, treatment ﬁeld, and
dose is presented in Fig 1.
Radical treatment plans were recommended for the majority of changes as compared with palliative plans, as
shown in Fig 2. Among all the treated sites, the most frequent changes were suggested in head and neck tumors
(42.3%). The breakdown of change recommendations for
all the treated regions is presented in Fig 3. When categorized by radiation planning techniques, 3D-CRT constituted the majority of the changes (50%), followed by
IMRT (38.5%). Technique-based recommendations for
change are displayed in Fig 4. There were no changes
recommended in the contour of organs at risk.
DISCUSSION
Radiation oncology involves complex sequential processes
of consultation, simulation, planning, and delivery of
treatment. With the involvement of so many personnel and
procedures, each stage is prone to mistakes, which may
have a negligible to profound effect on the quality of related
outcomes and may eventually compromise patient care.
Therefore, to manage these discrepancies, there has been
a desperate need for the implementation of a tool or intervention to ensure that patients receive treatment with
minimum chances of error that is evidence based and
appropriate to their medical condition.9 It is imperative to
note that AKU is accredited by the Joint Commission International as an academic medical center. The compliance to rigorous standards of patient safety and quality of
health care is binding.10 Furthermore, accreditation plays
an integral role in establishing methods to evaluate compliance with international standards.
QA aimed at improving outcomes and eliminating errors
plays a vital role in the ﬁeld of radiation medicine. Its importance in radiation oncology is even greater because of
the unique nature of the multiple phases involved. Quality
control indicators are established in an attempt to ensure
consistent, safe, and optimal delivery of radiation, meeting
the highest standards of care.5 Examples of such quality
indicators include review of treatment plans and port ﬁlms
by physicians and physicists, chart rounds, and timeouts
before treatment delivery.11 The quality management
TABLE 1. Operational Deﬁnitions
Change
Category

Deﬁnition

1. No change

No change made in treatment volumes, ﬁelds, or
doses

2. Major
change

Treatment volumes, ﬁelds, or doses not
acceptable

3. Minor
change

Changes made within treatment volumes, ﬁelds

4. Missing
contour

Treatment volume or organ at risk contour found
to be missing

2 © 2019 by American Society of Clinical Oncology
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TABLE 2. Frequencies of Treatment Intent, Tumor Sites, Treatment
Techniques, and Category of Changes
Variable

No. (%)

Intent of treatment
Radical

96 (82.8)

Palliative

20 (17.2)

Tumor site
Head and neck

47 (40.5)

Thorax

30 (25.9)

Pelvis

17 (14.7)

Brain

14 (12.1)

Abdomen

4 (3.4)

Extremity

2 (1.7)

Other

2 (1.7)

Treatment technique
2D

15 (12.9)

3D-CRT

71 (61.2)

IMRT

30 (25.9)

Category of changes
No change

90 (77.6)

Minor change

15 (12.9)

Major change

10 (8.6)

Missing contour

1 (0.9)

Abbreviations: 2D, two dimensional; 3D-CRT, three-dimensional
conformal radiation therapy; IMRT, intensity modulated radiation therapy.

guidelines focusing on measuring the functional performance of the radiotherapy equipment by measurable parameters have been provided by the American Association
of Physicists in Medicine.12-15 The American College of
Radiology, the American Society for Radiation Oncology,

and the European Society for Radiotherapy and Oncology
have also developed practical guidelines to ensure quality
control during radiation delivery.16,17
Peer review is a valuable tool that is central to QA programs
in health care. It is practiced widely among radiation oncologists and has several dimensions, including review of
treatment decision making, planning contours, and other
parameters including, but not limited to, prescribed dose,
target volumes, technique, and patient set-up.8 Cancer
Care Ontario deﬁnes peer review as the evaluation of the
components of a radiation treatment plan by a second
radiation oncologist.18 Peer review is generally the only
opportunity for radiation oncologists to evaluate each
other’s cases and radiation plans. The input of physicists
and radiation therapy technologists is highly valued,19 and
the Association of Physicists in Medicine has published
guidelines for a peer review process between two qualiﬁed
clinical radiation oncology physicists.20 Peer review generally leads to small but potentially signiﬁcant developments in professional practice and health care outcomes.
The success of review and feedback seems to depend on
baseline performance and on how the feedback is
provided.21 This becomes more important in developing
countries, which may lack expertise.22
There are a number of different formats for conducting peer
review. Most centers use peer review in multidisciplinary
groups that may or may not have a site-speciﬁc focus. The
timing of peer review also varies among different centers,
with a majority performing peer review before the initiation
of treatment.23 The concept of site-speciﬁc multidisciplinary team meetings, in which physicians from different
specialties and other members of the health care team
discuss patients with upcoming decision points, is
emerging in our country.24 However, there is a lack of
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FIG 1. Classiﬁcation of changes. CTV, clinical target volume.
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FIG 2. Categorization of changes with respect to treatment intent.

local control and poor survival.25 This also exposes the
surrounding normal tissues to excess doses of radiation
beyond their tolerance limits, resulting in higher toxicities.
This severity of toxicity warrants the use of precise techniques of delivering radiation.26

evidence about formal radiation oncology–speciﬁc meetings in Pakistan other than at AKU, where all radiation plans
are evaluated by a team of qualiﬁed and trainee radiation
oncologists.
The goal of highly conformal radiation techniques such as
3D-CRT and IMRT is to increase the likelihood of tumor
control by precisely shaping the dose distribution to the
target volume. The reliable delivery of high-quality therapy
poses a unique challenge. It is essential to account for all
possible sources of uncertainties in treatment planning if
we are to achieve this goal. It is the preliminary responsibility of the radiation oncologist during treatment
planning to precisely delineate the target volumes and
normal organs at risk. Inaccurate demarcation may lead to
a geographic miss of a high-risk region and hence, reduced

It is not uncommon to have a disagreement among radiation oncologists about the delineation of target structures,
which may invariably have an impact on disease-related
outcomes. Interobserver variability in target volumes for
cancer treatment with radiation therapy has been demonstrated in multiple studies.27-29 Lee et al30 performed
a study in which they investigated interobserver variation
among ﬁve radiation oncologists. Each radiation oncologist
was asked to contour the prostate independently on axial
computed tomography images 1 day after implanting
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interstitial needles. There were signiﬁcant interobserver
differences in the deﬁned prostate volume, which led to
signiﬁcant differences in dosimetry. Similarly, Logue et al31
reported signiﬁcant interphysician variability in producing
target volumes and radiation plans for conformal radiotherapy. These skills are enhanced by knowledge about
regional anatomy and patterns of failure; above all, the
physician’s experience plays an important role in drawing
a CTV.32 There is a need to quantify disagreements, and
additional effort to increase interobserver agreement is
required.
Several techniques and procedures have been developed to
overcome this variation. Contrast agents and metallic
markers have been used commonly to demonstrate the
anatomy during simulation to precisely delineate the target
volume and to increase the probability of tumor control.33
Valicenti et al34 presented a study in which seven radiation
oncologists delineated the prostate in groups of patients with
and without contrast medium. The study concluded that the
use of urethral and bladder contrast improved the reliability
of localizing the prostate. We routinely use contrast media
and markers as per international recommendations.
Inconsistency in contouring seems to be greater when
planning for adjuvant radiation therapy in postoperative
cases. The introduction of standardized contouring protocols has led to uniformity in delineation patterns among
physicians. In a study by Mitchell et al,35 the radiation plans
of three patients who had undergone a prostatectomy were
contoured by six radiation oncologists before and after,
providing a contouring atlas. A signiﬁcant reduction in
variability in target volume outlining was achieved by adhering to an evidence-based contouring protocol. The
importance of such protocols has also been highlighted by

Goodman et al,36 who presented stepwise contouring
guidelines and an atlas for the delineation of CTV in the
postoperative irradiation of pancreatic cancers. These
guidelines have helped physicians better determine areas
at risk and minimize dose to normal structures. The
planning target volume accounts for the patient set-up error
and internal target motion but not for the interobserver
variation in deﬁning the CTV.37
In our study, 26 plans out of 116 (22.6%) were recommended for changes; this frequency of change is much
higher than that reported in contemporary literature.38-40 All
the recommendations, major or minor, were implemented
by the primary radiation oncologist before the radiation
treatment plan was delivered to the treatment unit. In 2015,
the American Society for Radiation Oncology conducted
a nationwide survey related to peer review. The results
showed that 83% of radiation oncologists were involved in
the process, and among those, 90% changed their radiation plans because of peer review, with approximately 7%
to 10% of plans being changed.38 Boxer et al39 did a prospective real-time audit of 208 patients from June 2007 to
June 2008. Eight patients out of the 208 (3.8%) had
a change in management strategy recommended.
Brundage et al40 documented the pretreatment peer review
of 3,052 treatment plans over a period of 8 years. Out of the
3,052 audited radiation plans, 124 (4.1%) were identiﬁed
as having errors in radiation planning or prescription.
Modiﬁcations were made in 98 plans (3.2%) before
commencing radiation. The remainder went unchanged
because there were slight deviations from usual practice
because of individual patient characteristics.
Delineation of target volume has been identiﬁed as the most
common variable that is prone to any alteration. In our
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study, CTV was changed in a total of 19 cases (16.4%),
which is consistent with the literature.39,41 In the audit
performed by Boxer et al,39 most of the changes were
suggested in target volume coverage (2.9%), as compared
with prescribed dose and fractionation schedule. With the
use of precise radiation delivery techniques, the chances of
marginally missing the target volume are enhanced.
Therefore, there is a need to delicately contour the volumes
when using highly conformal radiation techniques. A multiinstitutional study by Lo et al41 reported changes in 66.7%
of stereotactic body radiation therapy plans for lung cancer
after peer review. The authors of this study concluded that
inadequate target volume coverage was the main compulsion behind any change recommendation. Our nascent
experience with IMRT has forced us to be extra cautious
during contouring and also to seek help from colleagues.
Although we most frequently use 3D-CRT in our center,
data show that IMRT plans resulted in the most changes in
CTV (ie, 10 out of 19).
Our study emphasizes the need for peer review and its
impact on the planning process, but several shortcomings
require additional attention. First, the sample size was too
small to draw any meaningful inferences. Second, we did
not compare the pre- and postreview changes in the target
volumes. It is the usual practice of our radiation oncologists
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